Novacyt
 | |
| Company type | Société Anonyme |
|---|---|
| LSE: NCYT Euronext: ALNOV | |
| Industry | Biotechnology |
| Founded | 2006 |
| Headquarters | Camberley, Surrey, United Kingdom |
Key people | David Allmond (CEO) |
| Products | In vitro and molecular diagnostics |
| Subsidiaries | |
| Website | www.novacyt.com |
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France.[1][2] The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide.[3] Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.[4]
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV.[5][6][7][8] The test was approved as eligible for procurement under the World Health Organization's (WHO) Emergency Use Listing process in April 2020,[9] meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response.[10] In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory.[11][12]
References
- ^ "Offices". Novacyt. Retrieved 1 February 2020.
- ^ "How dangerous is the coronavirus and how does it spread?". Financial Times. Retrieved 1 February 2020.
- ^ "Novacyt launches research-only Wuhan virus test". The Standard (Hong Kong). Retrieved 1 February 2020.
- ^ "Annual Report and Accounts for the year ended December 2018" (PDF). Novacyt. Retrieved 1 February 2020.
- ^ "Healthcare Company Novacyt Launches New Coronavirus Test". The New York Times. Retrieved 1 February 2020.
- ^ "Novacyt shares jump 32% on launch of coronavirus test". CNBC. Retrieved 1 February 2020.
- ^ "Chandlers Ford company Primerdesign launch novel coronavirus test". Southern Daily Echo. Retrieved 1 February 2020.
- ^ "Novacyt in prime position with coronavirus test". The Times. Retrieved 8 February 2020.
- ^ "WHO approves Novacyt's coronavirus testing kit". The Jerusalem Post. Retrieved 8 April 2020.
- ^ "WHO lists two COVID-19 tests for emergency use". World Health Organization. Retrieved 10 April 2020.
- ^ "Novacyt's Covid-19 diagnostic test gets OK for WHO procurement". London South East. Retrieved 8 April 2020.
- ^ "Novacyt joins AstraZeneca and GSK in UK effort on COVID-19 testing". The Pharma Letter. Retrieved 8 April 2020.
External links
 | This French corporation or company article is a stub. You can help Wikipedia by expanding it. |